Automatic analyzer for clinical chemistry

1 = 2 3 1.1.1 Titrator 1.1 4 1.1.2 Polarograph 5 1.1.3 Electrolytic analyzer 1.1.4 Coulometric analyzer 6 1.1.5 ph ORP ph meter and ORP meter 7 ph ORP 1.1.6 Electrode type oxgen meter 8 DO 1.1.7 Luminescent

‡ç‡¢‡Ó‡Ü‡Á‡Õ04-03„”

全ページ.indb

untitled

1 z q w e r t y x c q w 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 R R 32 33 34 35 36 MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR MR

ドコモP-01Hカタログ

2

1 = 2 3 r \ 1.1.1 Titrator 1.1 4 1.1.2 Polarograph 5 1.1.3.1 Electrolytic analyzer 1.1.3.2 Coulometric analyzer 6 1.1.4.1 ph ORP ph meter and ORP meter 7 ph ORP 1.1.4.2 Electrode type oxgen meter 8 DO

188 Diagnostic instruments Ultrasonic sistem diagnostic scanner HS-1500V

187 Diagnostic instruments Ultrasonic sistem diagnostic scanner HS-1500V Video copy Jelly for ultrasound Ultrasonic sistem diagnostic scanner HS-2100V Ultrasonic sistem diagnostic scanner HS-101V for pig

HO…−†[…t†QŁ\1

MacugenInsert01.ai

2

6 6 6 6 1 2 3 4 5 6 7 8 R B1 B1 1 2 3 4 5 6 7 8 9

6 6 6 6 1 2 3 4 5 6 7 8 R B1 B1 1 2 3 4 5 6 7 8 9 B1F 7306730 96730 1F & 1069 2F & & 93069 3F 4F 1069 969 5F 6F 7F & & 8F 8F 9F 8306515 96.0534582130 1068 1066 4.0534582180 83069 0120-53-4305 0534542218

1

H

CHEMOTHERAPY APR. 1982

VOL.30 S-1 CHEMOTHERAPY Table 1 Dose of CTT and subjects i. v.: Intravenous bolus injection d. i. v.: Intravenous drip infusion i. m.: Intramuscular injection Fig. 1 Schedule for examination of CTT, 1.0g

第138期事業報告書

H1-H4

untitled

1 JAPAN TESTING ASSOCIATION 2 3 JAPAN TESTING ASSOCIATION 4 5 JAPAN TESTING ASSOCIATION 6 7 JAPAN TESTING ASSOCIATION 8 9 JAPAN TESTING ASSOCIATION 10 11 JAPAN TESTING ASSOCIATION 12 13 JAPAN TESTING ASSOCIATION

untitled

IF_SUPRECUR_N29

! @ # $ % ^ & * ( ) _ + )# ! a s d a s d f g h a s d @ a s d a s # a s d f g h j $ a s d f g h a s d % a s a a s a s a s d f g ^ a s a s a s & a s d f a s d f g h a s d f g a s d f g a s d a s d * s

KRAS KRAS

KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS : KRAS in vitro KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS KRAS

: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 )

QMS (EVER) 0373852 (QMS) QMS QMS X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X

3 JAS JAS JAS 4

1 2 3 JAS JAS JAS 4 5 6 7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ph 102 106 K 31 32 13 3 15 79 33 34 35 36 37 20 6 H.22.3 http://www.caa.go.jp/foods/pdf/syokuhin19.pdf 38

<93F195D9837083938374838C8362836732303135303330362E706466>

2 index 3 4 Column 5 1 2 6 3 5 4 6 7 8 1 9 2 10 Column 11 2 12 13 2 14 Column 15 3 http://tokyo-frontier.com/ 16 4 17 5 18 6 Column 19 20 21 22 23 1872 1900 1940 1950 1975 1998 24 2001 2008 2011 2014 25

Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;

CRPNo30表紙.ai

No.30 2012/6 20126 Clinical Research Professionals No.30 17 18 Clinical Research Professionals No.30 2012 6 20126 Clinical Research Professionals No.30 19 20 Clinical Research Professionals No.30 2012

Green Light GxP HPLC 2

Excellence Plus Good Manufacturing Practice (GMP) 1 (OOS) (OOT) (OOE) 2 2 3 5 5 5 8 8 LevelControl 8 9 profact profact Advanced 9 TestManager 11 11 12 Green Light GxP HPLC 2 GMP GLP (USP) FDA (PAI) 7346.832

VOL. 25 NO. 6 CHEMOTHERAPY 1667

1666 CHEMOTHERAPY AUG. 1977 VOL. 25 NO. 6 CHEMOTHERAPY 1667 1668 CHEMOTHERAPY AUG. 1977 VOL. 25 NO. 6 CHEMOTHERAPY 1669 VOL. 25 NO. 6 CHEMOTHERAPY 1671 1672 CHEMOTHERAPY AUG. 1977 VOL. 25 NO. 6 CHEMOTHERAPY

取扱説明書[NE-202]

NE-202 13.3 m m 1 2 3 m 4 5 6 7 a a a 8 9 10 11 12 a a a a 13 14 15 16 17 2.4 FH 1/XX 4 18 19 20 21 22 23 24 25 26 27 1 2 3 4 5 6 m 7 h 8 r 9 a P b c d e f g h i j ud k l m n o 28 29 30 31 32 33 34 35

2

1) Urlne analysls 7)Serologlcal exam. 1 1)ECG W.N.L. sugar 0% CRP (-) urobillnogen N(+) RA (+) 12)Renal function albumin 3(+) ASLO (-) PSP test 15' 40

A case of membranoproliferative glomerulonephritis accompanied with hyper IgM immunodeficiency Kenichiro SHIGEMOTO, Koji WADA, Naoki HAMAGUCHI, Akira HIRABAYASHI, Shunji TOI, Koji USUI, Michiko ARITA,

H15 H2 H25 H26 H H さいたま64.% 49.9% H25 8

19 26 38 524 476 556 68 647 686 73 779 812 856 15 9 8 7 6 5 4 3 2 1 476 556 8 779 812 73 686 647 68 52 39 39 44 49 36 856 44 2 18 16 14 12 1 8 6 4 2 32 316 286 35.1 33.6 262 31.8 29.1 171 19 1 62 54 57

Scientific Instruments Visco, Concentration & Refractmeter

137 Scientific Instruments Visco, Concentration & Refractmeter 180 138 Scientific Instruments Visco, Concentration & Refractmeter 227 139 Scientific Instruments Visco, Concentration & Refractmeter 360

橡創薬基盤技術の開発（トップ３）全部まとめた分.PDF

JIS Z 9001:1998JIS Z 9002:1998 ISO/IEC 17025ISO/IEC Guide 25

JIS Q 17025 IDT, ISO/IEC 17025 IT JIS Z 9001:1998JIS Z 9002:1998 ISO/IEC 17025ISO/IEC Guide 25 JIS Q 17025 IDT, ISO/IEC 17025 IT IT JIS Q 17025ISO/IEC 17025 (2) JIS Z 9358 ISO/IEC Guide 58 (3) testing

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS

< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic

:,, : - 7 -

31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )

212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................

スペースプラズマ研究会-赤星.ppt

14 1 1 1 1 Pauline Faure 1 1 2 3 (1: 2: JAXA 3: IHI) IHI (C)(No.21560819) ISAS(JAXA) ISO TC20/SC14 / (Spall) 60~90% 2 (Cone) 1% (Jetting) CDV11227 Committee Draft for Comments CDV11227 Witness plate Sabot

18 20 A1c C HDL-LDL-C- A1c C CRP CRP ID-MS RF(PRL)(LH) (FSH)E2TSH -(hcg) AFPCEA)(FCM) RFPRLE2TSHhCGAFP CEA

18 19 5 18 20 A1c C HDL-LDL-C- A1c C CRP CRP ID-MS RF(PRL)(LH) (FSH)E2TSH -(hcg) AFPCEA)(FCM) RFPRLE2TSHhCGAFP CEA Title : Research and Development to Promote the Creation and Utilization of an Intellectual

008 Artificial insemination instruments Straw filling and sealing machine SFM-1/SFM-5

007 Artificial insemination instruments Straw filling and sealing machine T-10 Printing machine for straw semen tube Straw semen tubes, 133, 0.5mL / 0.25mL Dummy cow hydraulic type Dummy cow electric type

untitled

1 Physical Chemistry I (Basic Chemical Thermodynamics) [I] [II] [III] [IV] Introduction Energy(The First Law of Thermodynamics) Work Heat Capacity C p and C v Adiabatic Change Exact(=Perfect) Differential

200812 06 Development 2

200812 06 Development 2 200812 06 Research and Clinical Center for Child Development 4 (CP) MR MR, MR, MR( PDD, PDD, ADHD, 200812 06 Research and Clinical Center for Child Development 5 LD LD ADHD ADHD

PSCHG000.PS

untitled

DSP Research, Inc. 1 of 57 DSP Research Inc. 2005.05 Test Procedure DSP Research, Inc. 2 of 57 DSP Research Inc. 2005.05 Test Procedure DSP Research, Inc. 3 of 57 DSP Research Inc. 2005.05 Test Procedure

3 光毒性第三者評価報告書100924改

21 5 13 22 5 17 1 2 in vivo 24 in vivo 9 6 6 GLP 1 b 4 Acridine BMDM 4-t-butyl-4-methoxydibenzoylmethane CHD Chlorhexidine Bithionol CHD Bithionol in vivo in vivo b in vivo 70% b 5 in vitro 3T3-NRU 4 9

1m 2 4, 73 11,m 2 2,8 11,m , 7 6 6m 2 87m 2 1 2

CONTENTS 1 3 6 7 9 1 1m 2 4, 73 11,m 2 2,8 11,m 2 1 211, 7 6 6m 2 87m 2 1 2 6 1 2 3 4 9F 1F 11F 12F 13F 14F 8F 7F 6F F 1F 2F 3F 4F B2F B1F 9F 8F 7F 6F F 4F 3F 1F B2F B1F 2F 3.F 4 3 TOPICS 1 3 2 4 6 6 3,886

... 1... 1... 3... 10... 24... 39... 43... 44... 45... 52... 53... 55... 60... 64... 66... 69... 70... 72... 74... 78... 78... 79... 81... 82... 108... 110 1 2 -- 3 -- 4 5 6 7 -- 8 9 10 -- -- -- 11 --

SC210301 Ł\†EŒÚ M-KL.ec6

30 36 01 02 07 08 05 95 11 94 11 97 13 91 13 9T 14 15 15 96 16 BE 16 BF 16 BG 17 CL 17 00 17 17 17 1 180 28 28 180 2 180 181 60 180 180 90 32 180 30 15 29 29 30 14 3 15 30 29 29 14 30 14 19 19 30 30 22

Msx2

CHEMO THER APY Table 1. Background of the volunteers in the phase I clinical trial of ME1207 Table 2. Methods for Phase I clinical trial of ME1207 All doses are expressed in terms of potency as ME1206

untitled

http://www.ecompliance.co.jp 1.0 2006/05/26 Copyright(C) 2006 ecompliance Ltd. All Rights Reserved. Page 1 1.... 4 2.... 4 3.... 4 3.1... 4 3.2... 4 3.3... 4 3.4... 4 4.... 4 4.1... 4 4.2... 5 4.3... 5

untitled

1 3 2 4 3 4 4 4 5 5 6 6 1 7 2 7 3 9 4 9 1 11 2 11 3 11 4 12 5 13 6 17 7 17 8 17 1 18 2 18 3 18 4 19 5 20 6 21 7 21 8 21 1 22 2 25 3 31 2 3 4 5 2004 4 1 6 7 8 9 10 11 12 13 / Gas Assist Injection 14 15

2 3 1 1-2 -

w NEWS NEWS Y

No.472 FEB. 200315 w NEWS NEWS Y e r Y E t 1 1 y u i B 1 1 Y c fa g f o p mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr mr A 1 !0 1 1

w 1 h

9 No.467 SEP. 200214 w 1 h e NEWS NEWS Y r Y t y Y u 1 bf 1 i o !0 d f e Y 1 1 a c 1 !1 7 7 1 !2 e Y 1 de f 1 1 1 !3 1 1 b 71 Y Y Y Y !4 ga Y 7 7 1 E F E A Y u u u u u u u u u u u u u u u u u u u u u u

尿試験紙を用いたアルブミン・クレアチニン検査の有用性

Clinical effectiveness of the Urine Test Strip for albumin and creatinine Masataka Suzuki Eiken Chemical has newly developed the Urine Test Strip, ''URO PAPER TM '', for albumin and creatinine testing.

VOL.39 S-3

VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose

無印良品 キッチン・テーブル クリーニング・バス用品 2010春夏

200 6 6 7 8 2 4 6 6 7 7 7 2 8 8 9 9 9 20 20 2 22 22 22 24 24 24 25 26 26 28 28 29 29 30 30 3 www.muji.net 32 32 33 34 34 859275 35 39 4 42 35 36 35 37 36 38 39 40 40 40 4 4 42 44 43 45 46 47 47 48 49 50

無印良品 キッチン・テーブル・クリーニング・バス用品 2009 春夏

2009 2009 6 6 8 2 4 6 8 8 9 9 9 2 20 20 2 2 2 22 22 22 23 24 25 25 23 26 26 27 27 28 30 30 3 3 32 32 32 www.muji.net 34 34 35 35 35 36 36 37 37 37 38 39 854845 42 43 44 48 38 4 42 42 42 43 43 45 47 46

Type-it Mutation Detect PCR プロトコールとトラブルシューティング (2301449 11/2008)

June 2008 Type-it Mutation Detect PCR PCR SNPs 2 3 QIAxcel Agilent 2100 Bioanalyzer 8 13 17 Sample & Assay Technologies MSDS material safety data sheet Operon Biotechnologies www.operon.com TE 100 µm 20

本文／研究発表５

Analysis of User Behavior in Social TV System teleda ABSTRACT NHK R&D/No.134/2012.7 35 36 NHK R&D/No.134/2012.7 NHK R&D/No.134/2012.7 37 38 NHK R&D/No.134/2012.7 NHK R&D/No.134/2012.7 39 40 NHK R&D/No.134/2012.7

(a) (b) X Ag + + X AgX F < Cl < Br < I Li + + X LiX F > Cl > Br > I (a) (b) (c)

( 13 : 30 16 : 00 ) (a) (b) X Ag + + X AgX F < Cl < Br < I Li + + X LiX F > Cl > Br > I (a) (b) (c) (a) CH 3 -Br (b) (c),2,4- (d) CH 3 O-CH=CH-CH 2 (a) NH 2 CH 3 H 3 C NH 2 H CH 3 CH 3 NH 2 H 3 C CH 3

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS

< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic

PA_sogo_H1_H4_cc.ai

PARTICLE COUNTERS 2019~2020 PARTICLE COUNTERS 0.5 m INDEX 2 3 4 5 9 10 11 12 17 18 19 20 21 22 23 PARTICLE COUNTERS AIRBORNE PARTICLE COUNTERS AIR BORNE A NL A NL A A NL A NL PARTICLE COUNTERS LIQUID-BORNE

1 Blood chemistry Peripheral blood Viral marker TP 5.4 g dl WBC 4.310 3 ml Syphilis TPAb Alb 2.7 g dl RBC30210 4 ml HBsAg T. bil 2.3 mg dl Hb 11 g dl

2012; 18: 200 207 Necropsy 1 1 1 2 65 11 autoimmune hepatitisaih 14 21 1 5 13 Necropsy CHF1 A1 Kupffer cell hemosiderin Berlin blue KEY WORDS: hemochromatosis, autoimmune hepatitis, liver cirrhosis, necropsy

untitled

1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood

(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..

... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Fig. 1 The value of fungal index and D- arabinitol/creatinine. Fungal index was mesured by Endotoxin D and Endospecy

052 ET/ Embryonic cell fusion instruments Peltier ET freezer

051 ET/ Embryonic cell fusion instruments Peltier ET freezer Program freezer, ET-1N Automatic irrigator for embryo collection Restraining stall Ultrasound apparatus for ovum pick up Aspirator for OPU Incubator

橡図表リスト.PDF

3-2-3 3-54 The Basic Design Study on the Project for Construction and Supply of Medical Equipment for Princess Margaret Hospital in Tuvalu ITEMS Q'ty 1 Anesthesia Apparatus with Ventilator

アニサキスの刺入を内視鏡的に確認し得た上行結腸癌の1例　第54巻05号1656頁

2015_kisyuu

untitled

CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11

CHEMOTHERAPY SEPT. 1991

CHEMOTHERAPY SEPT. 1991 VOL. 39 S-3 Table 1. Background of characteristics and allocation of 9 healthy male volunteers in a single-dose study on betamipron Table 2. Background of characteristics and allocation

m

bac2017_00_15

2017 Faculty of Bioscience and Applied Chemistry Department of Frontier Bioscience Department of Chemical Science and Technology Department of Clinical Plant Science TEL:03-3264-9300 http://www.hosei.ac.jp/

Fig. 1. Structures of NM394, NAD-358 and NAD-245 Fig. 2. Typical HPLC chromatograms of NM394 in human plasma by organic solvent extraction method (a): Blank plasma (b): Plasma spiked with NM394 and internal

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

CHEMOTHERAPY Fig. 2 Urinary excretion of mezlocillin Fig. 1 Blood levels of mezlocillin CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels

F-03H

untitled

53 231029 53 INDEX 1 2 3 4 5 6 7 11 17 25 1 53 2310291210 1300 142 8666 1 5 8 TEL03 3784 8553FAX03 3784 5048 http://square.umin.ac.jp/eosj/index.html 53 125 8506 6 41 2 TEL03 3603 2111 3581FAX03 3602

(a) -4furne.ce Fig. I Schematic drawing of cooling chamber Fig. 2 Priventive gas velocity at nozzle 405

Fig. 1 Experimental Apparatus Fig. 2 Typical Ion Distribution in COG-Air Flame Fig. 3 Relation between Steel Temperature and Reduction Time (a) -4furne.ce Fig. I Schematic drawing of cooling chamber Fig.

Design and Implementation of Centralized Financial Management system 厦门大学博硕士论文摘要库

Design and Implementation of Centralized Financial Management system 2011 4 Internet JSP MVC JSPMVC Abstract Abstract With computer technology, network technology and information technology, more and

スライド 1

API Gas API Topics API Gas Gas Heater Gas Temparature Gas Topics API Gas API Gas Curtain Gas 60PSI API Gas Neblizer Gas Gas1 TurboIonSpray API Gas Heater Gas Gas1 Gas2 Gas2 API Gas Exhaust Gas Exhaust

The measurement of zinc protoporphyrin for iron deficiency anemia by hematofluorometer in children Makoto Migita, Yoshitaka Fukunaga and Masao Yamamot

The measurement of zinc protoporphyrin for iron deficiency anemia by hematofluorometer in children Makoto Migita, Yoshitaka Fukunaga and Masao Yamamoto Department of Pediatrics, Nippon Medical School Zinc

青森県2012-初校.indd

http://www.kairyudo.co.jp/ 2012 AOMORI 2 3 9 16 1 2 3 2010 6 128.9 128.2 128.7 8 9 31.7 30.0 31.7 30.0 22.5 21.4 21.9 21.0 117.2 116.7 116.3 115.8 65.1 64.9 64.7 64.5 7 25.3 24.0 24.9 23.5 123.1 122.5

1

1 VW EGR NOx NOx NOx (HC) SCR NOx (NH 3 ) 2L 2007 1,100 0 36 EA189 27 12 3L 2008 8.5 0 35 27 12 NO NO 2 NPO ICCT, International Council on Clean Transportation West Virginia University NOx EPA, Environmental

Physical and Psychological Effects of Stressors in Female College Students Reizou Mita*1, Konosuke Tomabechi*1, Isao Yamaguchi*1, Naoko Soeno*1, Shuhe

Physical and Psychological Effects of Stressors in Female College Students Reizou Mita*1, Konosuke Tomabechi*1, Isao Yamaguchi*1, Naoko Soeno*1, Shuhei Kobayashi*2, Mamoru Nishimuta*2, Michiyuki Shimizu*3,

2 English III Lecture Ready 1 Exploring Content 2 English IV Lecture Ready 1 Exploring Content 2 Microbiology II Chemistry of Biomolecules II Enzymology Biochemistry of Metabolism Physiology Plant Physiology

SPring8菅野印刷.PDF

20021219Spring-8 Ah/kg Ah/dm 3 Li -3.01 540 3860 2090 Na -2.71 970 1160 1140 Al -1.66 2690 2980 8100 Zn -0.76 7140 820 5800 Fe -0.44 7850 960 7500 Cd -0.40 8650 480 4100 Pb -0.13 11340 260 2900 H 2 0

卒業論文

1 2 3 A 4 6 ( ) (Bubble Flow) (Slug Flow) Churn Flow (Annular Flow) 7 Bubble Flow Slug Flow Churn Flow Annular Flow Fig.1.2.1 8 1961 Griffith Wallis..7 1 2.34 198 Taitel Dukler 1983 Fig.1.3.1. Taitel-Dukler

1

-1-

-1- -2 - 2000 1 1 5-3 - 21 10 2-4 - 5-5 - -6 - -7- -8 - 21 2000 21-9- IT in silico 10-10 - -11 - 20 21 1993 ICH - 12 - 2007 4 1 NIHThe National Institutes of Health2004 NIH NIH 2006 UK Clinical Research

GPC/SEC

GPC/SEC Agilent GPC/SEC...3... 5...5...7...9...11...12... 13...13...14... 15...15...16... 18...18...19 /... 21...21... 23 GPC/SEC...24 Q Q Q Q Q 35 GPC/SEC 24 365 GPC/SEC GPC/SEC GPC 2 80 % 2006 - Polyplasdone